Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Large Sell Order Still There This Morning

<< Previous

Bullboard Posts

Next >>

Comment by biorunon Mar 07, 2022 2:39pm

136 Views

Post# 34491798

RE:RE:RE:Large Sell Order Still There This Morning

so tickler, that was a long winded response to your standard response: maybe yes, maybe no, maybe maybe?. Lol

I take your point and I am not immune to BS. But if they actually do get an announcement off soon then I think we will all have to change our assessment tactics here about what/when we should take as gospel and what not.

I still think that confidence is very interesting in the least.

<< Previous

Bullboard Posts

Next >>

AI companies to invest in